This 108-page report marks the fifth installment in a series of reports on the topic of the Artificial Intelligence in Drug Discovery Industry that Deep Knowledge Analytics have been producing for more than 1 year now. We released the first edition of these reports, entitled “AI for Drug Discovery Landscape Overview 2017”, in the end of 2017, followed by “AI for Drug Discovery & Advanced R&D Q1 2018” in the first quarter of 2018, “AI for Drug Discovery & Advanced R&D Q2 2018” in the second quarter of 2018, “AI for Drug Discovery & Advanced R&D Q4 2018” in the first quarter of 2019.

​

The present edition consists of an updated overview of the state of the industry in Q1 of 2019, including extended coverage of major events in Q1 of 2019. It revisits the major insights, trends, data analytics, conclusions and forecasts of our previous report, analyzing which trends and conclusions are still on track, which ones have changed course, and which ones have been usurped by entirely new insights, trends and conclusions.

​